Grant: Discovery Grants Program - Individual
University of Toronto
$34,000.00
Underlying mechanisms of regulation of glycosphingolipid synthesis in cells
EF 2015-16
Résumé
Glycosphingolipids (GSLs) are sugar-lipid conjugates which play a key role in cell membrane processes and their deficiency or accumulation can result in many diseases. However, a central regulatory step in the synthesis of GSLs is essentially unknown. GSLs are made in a vesicular structure in cells called the Golgi. However, the one sugar GSL glucosyl ceramide(GlcCer), from which all more complex GSLs are derived, is made on the outside membrane of the Golgi. An enzyme called a 'flippase' must translocate glucosyl ceramide from the outside to the inside membrane of the Golgi. This regulates GSL synthesis but no GlcCer flippase has yet been identified. This is a major missing step in understanding GSL synthesis. We found the multiple drug resistance pump, MDR1, mediates ~50% of Golgi GlcCer flipping in spleen, kidney and liver. We will define the other GlcCer flippase(s) which translocate GlcCer into the Golgi in these, and the other, mouse organs. We will use molecular inhibitory technology for candidate flippases we identified by sequence alignment, and crosslinking to a photoaffinity derivative of GlcCer we will make, to identify these missing GlcCer flippases. Synthesis of acidic GSLs (containing sialic acid but also derived from GlcCer) is unaffected by MDR1, suggesting acidic GSLs can be made from a separate GlcCer source in the Golgi (translocated by a different flippase?). We showed cholesterol-GSL binding changes membrane GSL sugar from exposed/protruding, to flat/obscured. This change could inhibit enzymes making certain GSLs from GlcCer. As cholesterol content increases from early to late Golgi, the position of GlcCer in the Golgi stacks could define the type of GSL made. Different flippases may translocate GlcCer into different parts of the Golgi to provide different GlcCer pools (with different conformations).We showed loss of cell cholesterol induces synthesis of a new GSL, consistent with cholesterol control of GlcCer availability as a GSL precursor. Effect of increasing/decreasing cell cholesterol on GSL synthesis and action of the GlcCer flippases we identify will be determined. These studies will reveal a completely new regulation of cellular GSLs and define the major missing step in GSL metabolism.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
3470-2012
Name nom
Lingwood, Clifford
Department département
Laboratory Medicine and Pathobiology
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2012
Award amount
34000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5400
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Biochemistry
Research subject fr
Biochimie
Partie
4
Nb partie
5
Application title
Underlying mechanisms of regulation of glycosphingolipid synthesis in cells
Keyword
NSERC
Application summary
Glycosphingolipids (GSLs) are sugar-lipid conjugates which play a key role in cell membrane processes and their deficiency or accumulation can result in many diseases. However, a central regulatory step in the synthesis of GSLs is essentially unknown. GSLs are made in a vesicular structure in cells called the Golgi. However, the one sugar GSL glucosyl ceramide(GlcCer), from which all more complex GSLs are derived, is made on the outside membrane of the Golgi. An enzyme called a 'flippase' must translocate glucosyl ceramide from the outside to the inside membrane of the Golgi. This regulates GSL synthesis but no GlcCer flippase has yet been identified. This is a major missing step in understanding GSL synthesis. We found the multiple drug resistance pump, MDR1, mediates ~50% of Golgi GlcCer flipping in spleen, kidney and liver. We will define the other GlcCer flippase(s) which translocate GlcCer into the Golgi in these, and the other, mouse organs. We will use molecular inhibitory technology for candidate flippases we identified by sequence alignment, and crosslinking to a photoaffinity derivative of GlcCer we will make, to identify these missing GlcCer flippases. Synthesis of acidic GSLs (containing sialic acid but also derived from GlcCer) is unaffected by MDR1, suggesting acidic GSLs can be made from a separate GlcCer source in the Golgi (translocated by a different flippase?). We showed cholesterol-GSL binding changes membrane GSL sugar from exposed/protruding, to flat/obscured. This change could inhibit enzymes making certain GSLs from GlcCer. As cholesterol content increases from early to late Golgi, the position of GlcCer in the Golgi stacks could define the type of GSL made. Different flippases may translocate GlcCer into different parts of the Golgi to provide different GlcCer pools (with different conformations).We showed loss of cell cholesterol induces synthesis of a new GSL, consistent with cholesterol control of GlcCer availability as a GSL precursor. Effect of increasing/decreasing cell cholesterol on GSL synthesis and action of the GlcCer flippases we identify will be determined. These studies will reveal a completely new regulation of cellular GSLs and define the major missing step in GSL metabolism.